The company said it was able to develop the emulsion-based formulation for the drug in-house in just three weeks and has a capacity to manufacture 10,000 vials per day, which will be enough to cater to nearly 6,000 patients per month.
Copyright © 2024 | WordPress Theme by MH Themes